972. Imipenem-Cilastatin-Relebactam (I/R) Pharmacokinetics (PK) in Critically Ill Patients Supported on Extracorporeal Membrane Oxygenation (ECMO)

BACKGROUND: ECMO provides life-saving cardiac and/or pulmonary support to critically ill patients, but its effects on the PK of many antimicrobials remain unknown. Herein, we describe the PK of imipenem (IMI) and relebactam (REL) in critically ill patients supported on ECMO. METHODS: Patients with c...

Descripción completa

Detalles Bibliográficos
Autores principales: Fratoni, Andrew J, Kois, Abigail, Gluck, Jason A, Nicolau, David P, Kuti, Joseph L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Abstract
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678008/
http://dx.doi.org/10.1093/ofid/ofad500.027

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10678008/
http://dx.doi.org/10.1093/ofid/ofad500.027

Ejemplares similares